Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents
1998

Induction of DT-diaphorase by D3T in Human Tumor Cells

Sample size: 38 publication Evidence: high

Author Information

Author(s): GP Doherty, MK Leith, X Wang, TJ Curphey, A Begleiter

Primary Institution: University of Manitoba

Hypothesis

D3T analogues can increase DT-diaphorase activity in human tumor cells and enhance the anti-tumor activity of bioreductive agents.

Conclusion

D3T analogues significantly increased DT-diaphorase activity in 28 of 38 human tumor cell lines, enhancing the anti-tumor activity of agents like MMC and E09.

Supporting Evidence

  • D3T significantly increased DT-diaphorase activity in 28 of 38 human tumor cell lines.
  • The enhancement of anti-tumor activity paralleled the level of DT-diaphorase induction.
  • D3T did not significantly increase DT-diaphorase activity in normal kidney cells.

Takeaway

D3T helps cancer cells fight better against certain treatments by boosting a helpful enzyme, but it doesn't harm normal cells much.

Methodology

Human tumor cell lines were treated with D3T analogues, and DT-diaphorase activity was measured to assess the enzyme's induction and its effect on cytotoxicity of bioreductive agents.

Limitations

The study did not explore the long-term effects of D3T on normal cells or the exact mechanisms of enzyme induction.

Participant Demographics

Human tumor cell lines from various tissue types were used.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication